Please assess the completion status of the following clinical trial:

Trial Title: Reconstruction of Jaw Bone Using Mesenchymal Stem Cells

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:Patients presenting with an indication for an implant and wanting implant-borne prosthetic restoration.~* Patients presenting with lateral or vertical bone loss (focusing lateral bone loss) of the mandible behind the canine tooth.~* Lateral (width 5 mm or less) bone loss preventing the insertion of an implant without prior bone augmentation.~* Endentate for more than 6 months in the region requiring reconstruction.~* Endentate concerning at least 2 missing teeth in the region requiring reconstruction.~* Absence of clinical signs of infection in the region requiring reconstruction.~* Patients presenting with good dental hygiene (subjective criteria)~* Patients not presenting with any major oral pathologies.~* Dental crest size less than 5 mm.~General criteria:~* Adult patients over 18 and under 80 years of age.~* Patients in good general health presenting with a complete blood count and renal and hepatic function values within normal limits (confirmed by local laboratory tests).~* Patients with the capacity to understand medical information and give their informed consent.~Exclusion Criteria:~ocal criteria:~* Patients presenting with clinical or radiological signs of bone infection (acute or chronic osteomyelitis).~* Residual dentition close to the area requiring reconstruction with untreated endodontic disorder (apical granuloma or apical cyst).~* Untreated oral infection (cellulitis, periodontitis).~* Patients with poor hygiene (subjective criteria).~* Surgical procedure undertaken in the area requiring reconstruction less than 6 months prior to the bone graft.~* History of malignant tumors of the upper airways / digestive tract or of the jaw.~* History of or scheduled cervico-facial radiation therapy.~General criteria:~* The patient suffers from any serious coagulation disorders that could require substitution therapy~* The patient is receiving VKA therapy, which should be adjusted if necessary so that the INR does not exceed 2.5~* The patient has history of allergy to iodine or to local anesthetics(sulfites, etc.)., or a history of hematoma, or hemorrhage or blood coagulation disorders~* The patient has received localized iliac crest radiotherapy contraindicating withdrawal from the irradiated site~* The patient has major skin lesions or diseases.~* Patients presenting with bone metabolism disorders: hypophosphatemia, primary parathyroid osteitis or that is secondary to chronic renal insufficiency or osteomalacia, Paget's disease, vitamin D-related disorders, osteoporosis.~* Pregnant or breastfeeding women or women not using effective contraception if they are of childbearing age.~* Patients presenting with cancerous disorders (carcinoma, sarcoma, leukemia, lymphoma) or psychiatric disorders or with uncontrolled systemic diseases (diabetes, hypertension), or chronic renal disease.~* Severe bruxism.~* History of chemotherapy.~* Smoking or alcohol addiction. Occasional consumption of alcohol and/or smoking will be noted in the case report form.~* Patients with an ASA score of 0 or 1, incapable of tolerating general anesthesia.~* Immunosuppression~* Body mass index outside the normal range, particularly \>30 because of increased surgical risk at the time of BM harvesting from the iliac crest.~* Risk of remote infection (orthopedic prosthesis implanted in the previous 6 months, patients presenting with a high risk of infective endocarditis, presence of pulmonary arteriovenous shunt, etc.).~* HIV, HTLV and/or syphilis seropositivity.~* Hepatitis B or C infection.~* Active autoimmune disease.~* History of immunosuppressant treatment or bone marrow treatment.~* Administration of treatment interfering with bone metabolism.~* Patients requiring antibiotic prophylaxis before any dental procedure~* Patients reticent to undergo dental care or periodontal treatment~* Concomitant treatments: history of treatment or current treatment with bisphosphonates, long term corticosteroid treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Augmentation of new alveolar bone (Type: EXPERIMENTAL): Augmentation of atrophied alveolar ridge with mesenchymal stem cells( MSC) and bis calcium phosphate(BCP)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete